Quality key factors
Factor
Value
Sales Growth (5y)
8.80%
EBIT Growth (5y)
5.98%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
49.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
4.70
EV to EBIT
18.32
EV to EBITDA
15.47
EV to Capital Employed
4.46
EV to Sales
4.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
24.32%
ROE (Latest)
23.31%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -0.2% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 1.81 times
-3What is not working for the Company
INTEREST(Q)
Highest at SAR 1.16 MM
Here's what is working for Middle East Pharmaceutical Industries Co.
Inventory Turnover Ratio
Highest at 1.81 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -0.2% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Middle East Pharmaceutical Industries Co.
Interest
At SAR 1.16 MM has Grown at 106.92%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)
Interest
Highest at SAR 1.16 MM
in the last five periods and Increased by 106.92% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)






